Core Viewpoint - The transaction involves the acquisition of 16 target companies, allowing the listed company to hold 100% equity of the target assets directly and indirectly, which is a strategic move to enhance its health examination service offerings and optimize its industry layout [1]. Group 1: Transaction Necessity and Funding Arrangement - The acquisition is a commitment fulfillment by the actual controller and aims to resolve industry competition, while also expanding the breadth and depth of health examination services [2]. - As of March 31, 2025, the company's cash reserves are projected to be CNY 2.299 billion, but a minimum cash reserve of CNY 1.3525694 billion is required, indicating potential liquidity pressure [2]. - Issuing shares to acquire the target assets is deemed reasonable to avoid liquidity risks [2]. Group 2: Goodwill Impairment Risk - The transaction is expected to generate goodwill of CNY 275 million, representing 3.15% of net assets and 1.39% of total assets by the end of 2024 [3]. - A sensitivity analysis indicates that a 20% impairment of the new goodwill could lead to a 13.43% decrease in net profit, a 0.63% decrease in net assets, and a 0.27% decrease in total assets for 2024 [3]. Group 3: Performance Fluctuations of Target Assets - Some target companies experienced revenue fluctuations, with five companies, including Ningde Meinian and Sanming Meinian, seeing revenue declines of over 5% in 2024 due to external factors [4]. - Revenue declines in 2025 for companies like Hengyang Meinian and Wuhan Aoya were attributed to delayed government group examinations and other sporadic factors [4]. - Gross profit margins vary significantly among target companies due to differences in regional economic conditions, cost structures, and business models [4]. Group 4: Accounts Receivable and Debt Servicing Ability - As of September 2025, the accounts receivable collection situation for target companies is generally normal, with major debtors being government agencies and institutions [5]. - The provision for bad debts is more conservative compared to industry peers, with a significantly higher provision rate for receivables over one year [5]. - Overall, the asset-liability ratio of target companies is higher than industry averages, but primarily consists of operational liabilities, with sufficient cash flow to meet daily operational needs [5]. Group 5: Related Transactions and Fund Occupation - Target companies have engaged in related party transactions, with Anhui Meixin accounting for 83.76% of the highest package income in 2024 [6]. - Pricing for related transactions follows fair pricing guidelines, with settlement ratios between 60%-80% [6]. - Any related party fund borrowings have been repaid prior to the submission of application materials to the Shenzhen Stock Exchange, indicating no non-operational fund occupation [6]. Group 6: Auditor's Verification Opinion - The auditor believes that the transaction has commercial substance, with the income from the target assets being genuine and cost expenses being complete [7]. - The provision for bad debts on accounts receivable is deemed sufficient, and the pricing of related transactions is fair, with no evidence of benefit transfer [7].
美年健康回复深交所问询函 详解16家标的资产收购相关问题